Breaking News: HNF to Host “Revolutionizing Clinical Trials” Panel at Bio 2024

by | Feb 5, 2024 | 0 comments

Breaking News: HNF to Host “Revolutionizing Clinical Trials” Panel at Bio 2024

HNF is thrilled to announce that we have been accepted to host a 1-hour panel discussion during the Bio International Convention in San Diego, CA, in June 2024.

The session titled “Revolutionizing Clinical Trials Patient Registries, Wearable Tech, and Video Capture” will include experts from the FDA, Novartis, Stanford University, Across Healthcare, and HNF Founder and CEO, Allison Moore.

The Bio International Convention is the industry’s premier event, hosting thousands from across the global biotech ecosystem to focus on the future of bringing treatments to market.  HNF’s session attendees will gain insight into the dynamic fusion of patient-led registries like GRIN, wearable tech, and video capture, unveiling unprecedented opportunities in clinical trials championed by patient advocates and fostering patient-centric innovation.

This dynamic panel will include:

Moderator: Peggy Allred, Senior Director, Translational Medicine Novartis Institutes for BioMedical Research (NIBR), Novartis

Speaker: Michelle Campbell, PhD Associate Director, Stakeholder Engagement & Clinical Outcomes, Office of Neuroscience, FDA

Speaker: Jason Colquitt, CEO, Across Healthcare

Speaker: Tina Duong, PhD, Director, Clinical Outcomes R&D Stanford University

Speaker: Allison Moore, Founder/CEO, Hereditary Neuropathy Foundation

We are excited to be able to showcase this important topic on the “big stage” and represent the Charcot-Marie-Tooth Community.

Learn more on this topic

Related Blog Posts

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news